State-of-the-art lecture on closing the evidence-to-practice gap in cardiovascular pharmacotherapy: where are we still failing?

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Professor Deepak Bhatt

Icahn School of Medicine at Mount Sinai, New York City (United States of America)

4 More presentations in this session

Presentation thumbnail

Impact of oral semaglutide on cardiovascular risk factors in patients with type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease: a SOUL post hoc analysis

Professor S. Mulvagh (Halifax, CA)

Abstract Slides Video

Presentation thumbnail

Efficacy of sotagliflozin among older adults: a pooled analysis of SCORED and SOLOIST-WHF

Doctor R. Aggarwal (Boston, US)

Abstract Slides Video

Presentation thumbnail

Undertreatment of women with lipid-lowering therapies in four European countries: results from the prospective, non-interventional MILOS Study

Professor I. Gouni-Berthold (Cologne, DE)

Abstract Slides Video

Presentation thumbnail

Effects of icosapent ethyl on risk and duration of hospitalizations and death in REDUCE-IT

Doctor D. Bhatt (New York City, US)

Abstract Slides Video

Access the full session

Session thumbnail

Closing the evidence-to-practice gap in cardiovascular pharmacotherapy: where are we still failing?

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Session

Closing the evidence-to-practice gap in cardiovascular pharmacotherapy: where are we still failing?

Congress Session

Challenges in the implementation of therapies for long-term management in coronary artery disease

Congress Session

Before the first missed beat: addressing LDL-C management before an event

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources